BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7686200)

  • 1. An enzyme immunoassay for carcinoembryonic antigen (CEA) with homogeneous reactivity to different CEA preparations and low cross-reactivity with CEA-related normal antigens.
    Nagasaki H; Watanabe S; Kuroki M; Matsumoto Y; Murakami M; Omoda N; Kondo N; Jinnai H; Takaoka H; Matsuoka Y
    J Immunol Methods; 1993 Jun; 162(2):235-45. PubMed ID: 7686200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction profiles of seven enzyme immunoassay kits for carcinoembryonic antigen (CEA) analyzed with purified preparations of CEA and related normal antigens.
    Kuroki M; Haruno M; Arakawa F; Wakisaka M; Matsuoka Y
    Clin Biochem; 1992 Feb; 25(1):29-35. PubMed ID: 1551238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major disagreements between immunoassays of carcinoembryonic antigen may be caused by nonspecific cross-reacting antigen 2 (NCA-2).
    Börmer OP
    Clin Chem; 1991 Oct; 37(10 Pt 1):1736-9. PubMed ID: 1914175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of the nonspecific cross-reacting antigen using various related recombinant proteins expressed in Chinese hamster ovary cells and eight distinct monoclonal antibodies.
    Kuroki M; Haruno M; Murakami M; Wakisaka M; Oikawa S; Nakazato H; Matsuoka Y
    Immunol Invest; 1992 Apr; 21(2):143-58. PubMed ID: 1374735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer.
    Kuroki M; Matsumoto Y; Arakawa F; Haruno M; Murakami M; Kuwahara M; Ozaki H; Senba T; Matsuoka Y
    J Immunol Methods; 1995 Mar; 180(1):81-91. PubMed ID: 7897248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
    Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
    Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic reactivities of purified preparations of carcinoembryonic antigen (CEA) and related normal antigens using four different radioimmunoassay systems for CEA.
    Kuroki M; Yamaguchi A; Koga Y; Matsuoka Y
    J Immunol Methods; 1983 May; 60(1-2):221-33. PubMed ID: 6406604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies.
    Ikeda S; Kuroki M; Haruno M; Oikawa S; Nakazato H; Kosaki G; Matsuoka Y
    Mol Immunol; 1992 Feb; 29(2):229-40. PubMed ID: 1371822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
    Matsuoka Y; Kuroki M; Koga Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
    Kuroki M; Arakawa F; Higuchi H; Matsunaga A; Okamoto N; Takakura K; Matsuoka Y
    Jpn J Cancer Res; 1987 Apr; 78(4):386-96. PubMed ID: 2438262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
    Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
    Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
    Burtin P; Chavanel G; Hendrick JC; Frenoy N
    J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CEA and related antigens as possible new tumor markers].
    Matsuoka Y
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
    Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
    Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
    Audette M; Buchegger F; Schreyer M; Mach JP
    Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker.
    Kuroki M; Matsushita H; Matsumoto H; Hirose Y; Senba T; Yamamoto T
    Anticancer Res; 1999; 19(6C):5599-606. PubMed ID: 10697625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and biochemical characterization of the nonspecific cross-reacting antigen epitopes using twenty-three monoclonal antibodies.
    Kuroki M; Arakawa F; Higuchi H; Haruno M; Wakisaka M; Matsuoka Y
    Hybridoma; 1991 Oct; 10(5):557-74. PubMed ID: 1725168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen (CEA).
    Buchegger F; Mettraux C; Accolla RS; Carrel S; Mach JP
    Immunol Lett; 1982 Aug; 5(2):85-91. PubMed ID: 6759373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants.
    Daniel S; Nagel G; Johnson JP; Lobo FM; Hirn M; Jantscheff P; Kuroki M; von Kleist S; Grunert F
    Int J Cancer; 1993 Sep; 55(2):303-10. PubMed ID: 7690348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.